Changes in Inpatient Electroconvulsive Therapy Utilization Between 2019 and 2020: A National Inpatient Sample Analysis.
Journal
The journal of ECT
ISSN: 1533-4112
Titre abrégé: J ECT
Pays: United States
ID NLM: 9808943
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
pmc-release:
01
09
2024
medline:
31
8
2023
pubmed:
8
4
2023
entrez:
7
4
2023
Statut:
ppublish
Résumé
Electroconvulsive therapy (ECT) is an essential procedure for a range of psychiatric conditions. Multiple single-center studies have documented reduction in ECT administration in 2020 because of the coronavirus disease 2019 pandemic, but there have been little nationally representative data from the United States. The aim of this study was to examine the demographics of patients receiving ECT in 2019 and 2020 and to characterize temporal and regional variations in ECT utilization. The 2019 and 2020 National Inpatient Sample, an administrative database of inpatient hospitalizations in the United States, was queried for hospitalizations involving the delivery of ECT based on procedural codes. Overall number of ECT procedures was calculated based on the overall number of ECT procedural claims. In the 2019 NIS, 14,230 inpatient hospitalizations (95% confidence interval, 12,936-15,524) involved the use of ECT, with a cumulative 52,450 inpatient ECT procedures administered. In 2020, the number of inpatient hospitalizations with ECT decreased to 12,055 (95% confidence interval, 10,878-13,232), with a 10.0% reduction in overall procedures to 47,180. Whereas January and February ECT hospitalizations were comparable in both years, ECT hospitalizations decreased by more than 25% in March through May 2020 relative to 2019 volume. There was regional variability in the change in ECT utilization between 2019 and 2020. Electroconvulsive therapy use among general hospital inpatients declined between 2019 and 2020, with regional variability in the magnitude of change. Further study is warranted into the root causes and optimal responses to these changes.
Identifiants
pubmed: 37027490
doi: 10.1097/YCT.0000000000000917
pii: 00124509-202309000-00011
pmc: PMC10514222
mid: NIHMS1875729
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
173-178Subventions
Organisme : NIMH NIH HHS
ID : R01 MH112737
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH120991
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH112485
Pays : United States
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Espinoza RT, Kellner CH. Electroconvulsive therapy. N Engl J Med . 2022;386:667–672.
Munk-Olsen T, Laursen TM, Videbech P, et al. All-cause mortality among recipients of electroconvulsive therapy: register-based cohort study. Br J Psychiatry . 2007;190:435–439.
Rhee TG, Sint K, Olfson M, et al. Association of ECT with risks of all-cause mortality and suicide in older Medicare patients. Am J Psychiatry . 2021;178:1089–1097.
Espinoza RT, Kellner CH, McCall WV. Electroconvulsive therapy during COVID-19: an essential medical procedure — maintaining service viability and accessibility. J ECT . 2020;36:78–79.
Sienaert P, Lambrichts S, Popleu L, Van Gerven E, Buggenhout S, Bouckaert F. Electroconvulsive therapy during covid-19-times: our patients cannot wait. The American Journal of Geriatric Psychiatry [Internet]. 2020. Cited May 20, 2020. Available at: http://www.sciencedirect.com/science/article/pii/S1064748120302979 . Accessed October 10, 2022.
Amad A, Magnat M, Quilès C, et al. Évolution de l'activité d'électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19 [Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic]. L'Encéphale . 2020;46(3, Supplement):S40–S42.
Demchenko I, Blumberger DM, Flint AJ, et al. Electroconvulsive therapy in Canada during the first wave of COVID-19: results of the “What Happened” national survey. J ECT . 2022;38:52–59.
Braithwaite R, Chaplin R, Sivasanker V. Effects of the COVID-19 pandemic on provision of electroconvulsive therapy. BJPsych Bull . 2022;46:137–140.
Kwan E, Le B, Loo CK, et al. The impact of COVID-19 on electroconvulsive therapy. J ECT . 2022;38:45–51.
Trivedi C, Motiwala F, Mainali P, et al. Trends for electroconvulsive therapy utilization in children and adolescents in the United States from 2002 to 2017: a nationwide inpatient sample analysis. J ECT . 2021;37:100–106.
Trivedi C, Manikkara G, Zhang M, et al. ECT utilization in the treatment of catatonic patients in the United States: a nationwide in-patient sample analysis. J ECT . 2021;37:107–111.
Purushothaman S, Fung D, Reinders J, et al. Electroconvulsive therapy, personal protective equipment and aerosol generating procedures: a review to guide practice during coronavirus disease 2019 (COVID-19) pandemic. Australas Psychiatry . 2020;28:632–635.
Tor PC, Tan J, Loo C. Model for ethical triaging of electroconvulsive therapy patients during the COVID-19 pandemic. BJPsych Bull . 2021;45:175–178.
Luccarelli J, Fernandez-Robles C, Fernandez-Robles C, et al. Modified anesthesia protocol for electroconvulsive therapy permits reduction in aerosol-generating bag-mask ventilation during the COVID-19 pandemic. Psychother Psychosom . 2020;89:314–319.
Luccarelli J, Henry ME, McCoy TH Jr. Demographics of patients receiving electroconvulsive therapy based on state-mandated reporting data. J ECT . 2020;36:229–233.
Lambrichts S, Vansteelandt K, Crauwels B, et al. Relapse after abrupt discontinuation of maintenance electroconvulsive therapy during the COVID-19 pandemic. Acta Psychiatr Scand . 2021;144:230–237.
Methfessel I, Besse M, Belz M, et al. Effectiveness of maintenance electroconvulsive therapy—evidence from modifications due to the COVID-19 pandemic. Acta Psychiatr Scand . 2021;144:238–245.
Wachtel LE. Far from an elective procedure: electroconvulsive therapy and autism in the era of COVID-19. J ECT . 2021;37:10–12.
Elias A, Phutane VH, Clarke S, et al. Electroconvulsive therapy in the continuation and maintenance treatment of depression: systematic review and meta-analyses. Aust N Z J Psychiatry . 2018;52:415–424.
Luccarelli J, McCoy TH Jr., Seiner SJ, et al. Maintenance ECT is associated with sustained improvement in depression symptoms without adverse cognitive effects in a retrospective cohort of 100 patients each receiving 50 or more ECT treatments. J Affect Disord . 2020;271:109–114.
Kellner CH, Husain MM, Knapp RG, et al. A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study. Am J Psychiatry . 2016;173:1110–1118.
Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE). Arch Gen Psychiatry . 2006;63:1337–1344.
Kellner CH, Husain MM, Knapp RG, et al. Right unilateral ultrabrief pulse ECT in geriatric depression: phase 1 of the PRIDE study. Am J Psychiatry . 2016;173:1101–1109.
Green LW, Allegrante JP. Practice-based evidence and the need for more diverse methods and sources in epidemiology, public health and health promotion. Am J Health Promot . 2020;34:946–948.
Johnson EK, Nelson CP. Values and pitfalls of the use of administrative databases for outcomes assessment. J Urol . 2013;190:17–18.
Davis KAS, Sudlow CLM, Hotopf M. Can mental health diagnoses in administrative data be used for research? A systematic review of the accuracy of routinely collected diagnoses. BMC Psychiatry . 2016;16:263.